Want to see HK:1830 full AI Analyst Report?
Top Page
Perfect Medical Health Management Limited
(1830)
Select Model
Select Model
Rating:70Outperform
Price Target:
HK$1.50
▲(20.00% Upside)
Action:Reiterated
Date:10/19/26
The score is supported primarily by strong financial quality (healthy margins, strong free cash flow, and improved leverage) and attractive valuation (low P/E and high dividend yield). Offsetting these positives are weak technicals—price below major moving averages with negative MACD and low RSI/Stoch—plus the fundamental concern of two years of revenue decline.
Positive Factors
Strong Profitability
Gross, EBIT, and net margins of roughly 47%, 22%, and 19% show the company remains meaningfully profitable despite recent contraction. This profitability provides an operating cushion and supports reinvestment, pricing resilience, and continued service delivery over the next several quarters.
Negative Factors
Revenue Contraction
Revenue declined for two consecutive years, with reported revenue growth of about -14.7%. Persistent top-line contraction can weaken operating leverage, reduce scale benefits, and make future profit growth harder unless customer demand and sales momentum recover over coming periods.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong Profitability
Gross, EBIT, and net margins of roughly 47%, 22%, and 19% show the company remains meaningfully profitable despite recent contraction. This profitability provides an operating cushion and supports reinvestment, pricing resilience, and continued service delivery over the next several quarters.
Read all positive factors
Perfect Medical Health Management Limited (1830) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$1.43B
Dividend Yield12.76%
Average Volume (3M)280.33K
Price to Earnings (P/E)8.0
Beta (1Y)0.62
Revenue Growth-14.68%
EPS Growth-13.60%
CountryHK
Employees787
SectorHealthcare
Sector Strength45
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)0.14
Shares Outstanding1,256,197,800
10 Day Avg. Volume315,983
30 Day Avg. Volume280,331
Financial Highlights & Ratios
PEG Ratio-0.64
Price to Book (P/B)3.63
Price to Sales (P/S)1.46
P/FCF Ratio4.55
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.23
Revenue Forecast (FY)HK$1.22B
Perfect Medical Health Management Limited Business Overview & Revenue Model
Company Description
Operating as an investment holding firm, Perfect Medical Health Management Limited delivers a comprehensive suite of medical and aesthetic services across Hong Kong, mainland China, Macau, Singapore, and Australia. Its offerings encompass medical ...
Perfect Medical Health Management Limited Financial Statement Overview
Summary
Income Statement
64
Positive
Balance Sheet
78
Positive
Cash Flow
82
Very Positive
| Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 962.35M | 1.13B | 1.39B | 1.39B | 1.35B |
| Gross Profit | 454.45M | 719.22M | 911.37M | 662.60M | 689.93M |
| EBITDA | 369.52M | 441.97M | 596.91M | 592.40M | 602.84M |
| Net Income | 178.72M | 206.90M | 315.80M | 315.64M | 305.25M |
Balance Sheet | |||||
| Total Assets | 834.20M | 935.91M | 1.22B | 1.30B | 1.28B |
| Cash, Cash Equivalents and Short-Term Investments | 294.93M | 386.80M | 567.40M | 656.85M | 454.37M |
| Total Debt | 134.58M | 216.65M | 268.73M | 240.35M | 311.07M |
| Total Liabilities | 446.33M | 557.18M | 725.00M | 684.02M | 786.93M |
| Stockholders Equity | 387.86M | 379.95M | 497.51M | 612.27M | 494.27M |
Cash Flow | |||||
| Free Cash Flow | 309.22M | 298.23M | 445.50M | 533.81M | 372.16M |
| Operating Cash Flow | 339.48M | 332.88M | 497.12M | 560.55M | 516.71M |
| Investing Cash Flow | -180.16M | -171.93M | 162.56M | -222.51M | 8.05M |
| Financing Cash Flow | -269.94M | -477.95M | -520.97M | -335.02M | -565.97M |
Perfect Medical Health Management Limited Technical Analysis
Negative
1.25
Price Trends
1.24
Negative
1.23
Negative
1.18
Negative
Market Momentum
-0.03
Negative
37.54
Neutral
67.10
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1830, the sentiment is Negative. The current price of 1.25 is above the 20-day moving average (MA) of 1.16, above the 50-day MA of 1.24, and above the 200-day MA of 1.18, indicating a bearish trend. The MACD of -0.03 indicates Negative momentum. The RSI at 37.54 is Neutral, neither overbought nor oversold. The STOCH value of 67.10 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:1830.
Perfect Medical Health Management Limited Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | HK$1.43B | 8.01 | 43.78% | 12.76% | -14.68% | -13.60% | |
56 Neutral | HK$6.03B | 14.00 | 6.50% | 20.98% | ― | ― | |
52 Neutral | HK$248.00M | -24.54 | -77.06% | 3.14% | -38.43% | -394.12% | |
52 Neutral | HK$1.80B | 49.26 | 6.47% | ― | 2.78% | -41.23% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
50 Neutral | HK$67.84M | -37.50 | -0.93% | 6.43% | -2.31% | 66.07% | |
48 Neutral | HK$17.95M | -0.76 | -17.95% | ― | -26.00% | -188.55% |
* Healthcare Sector Average
HK:1830
Perfect Medical Health Management Limited
1.14
-0.08
-6.79%
HK:1448
Fu Shou Yuan International Group
2.64
-0.25
-8.69%
HK:0919
Modern Healthcare Technology Holdings Limited
0.08
<0.01
4.17%
HK:8296
Sino-Life Group Limited
0.19
-0.19
-50.00%
HK:8483
Max Sight Group Holdings Limited
0.31
0.22
248.31%
HK:2521
Shenghui Cleanness Group Holdings Limited
0.93
0.53
131.25%
Perfect Medical Health Management Limited Corporate Events
Perfect Medical Announces Board Resignation and Committee Reshuffle
Sep 30, 2026
Perfect Medical Health Management Limited has announced the resignation of independent non-executive director Mr. Chi Chi Hung, Kenneth, effective 30 September 2026. His departure also covers his roles as chairman of the remuneration committee and...
Perfect Medical Updates Board and Committee Structure to Strengthen Governance
Sep 30, 2026
Perfect Medical Health Management Limited has outlined the composition of its board of directors effective 30 September 2026, led by Chairman and Chief Executive Officer Dr. Au-Yeung Kong and supported by three executive and three independent non-...
Perfect Medical Wins Strong Shareholder Backing at AGM
Aug 7, 2026
Perfect Medical Health Management Limited reported that all resolutions at its 7 August 2026 annual general meeting were passed by poll with overwhelming shareholder support, including adoption of the audited results for the year ended 31 March 20...
Perfect Medical Proposes Re-Appointment of PwC as Auditor
Jul 21, 2026
Perfect Medical Health Management Limited, a Cayman Islands-incorporated company listed in Hong Kong, operates in the healthcare and medical services sector. Its group’s business scope and operational scale have remained largely unchanged fr...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.